ClinicalTrials.Veeva

Menu

mHealth-CArdiac REhabilitation for INOCA

NYU Langone Health logo

NYU Langone Health

Status

Enrolling

Conditions

Ischemia

Treatments

Behavioral: Communication with exercise therapist
Behavioral: Wearable activity monitoring device
Behavioral: mHealth-CR

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT06829160
23-01040
1R01HL170666-01 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This is a multi-site phase II, 2:1 pragmatic randomized trial of 250 participants within the NYU Langone Health (NYULH) and Emory University Medical Center system to evaluate mobile health cardiac rehabilitation (mHealth-CR) in patients who meet clinical criteria for INOCA (ischemia and no obstructive coronary disease on imaging). Participants will be randomized to mHealth-CR or usual care. The study intervention takes place for 3 months which is the time period for most traditional CR programs.

The overall study goals are threefold: 1) to evaluate whether an mHealth-CR intervention that includes activity tracking, weekly counseling, and exercise documentation, improves health status (i.e., symptoms, function, and quality of life) in patients with INOCA at 3 months; 2) to evaluate effects of the mHealth-CR intervention vs. usual care on physical activity and exercise capacity, general health status, and depressive symptoms (secondary endpoints). We will also evaluate effects on primary and secondary outcomes at 6 months and 1 year; and 3) to characterize engagement and elucidate any factors that limit engagement.

Enrollment

250 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18 and over
  • Diagnosis of Ischemia with Non-Obstructive Coronary Arteries (INOCA) based on evidence of ischemia and/or ischemic symptoms, plus non-obstructive Coronary artery disease (CAD) on computed tomography (CT) or invasive angiography

Exclusion criteria

  • Seattle Angina Questionnaire (SAQ) = 100
  • Non-ambulatory
  • Pregnant
  • Moderate or severe cognitive impairment
  • Unable/willing to provide consent
  • Incarcerated
  • Unable to use mHealth
  • Severe osteoarthritis or joint replacement within 3 months
  • Parkinsons disease or other movement disorders
  • Regular use of walker
  • Life expectancy < 12 months
  • Clinical judgement concerning other safety or non-adherence issues
  • Unable to read and communicate in English since the app content is currently only available in English.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

250 participants in 2 patient groups

mHealth-Cardiac Rehabilitation (CR)
Experimental group
Description:
Participants in the mHealth-CR arm will receive daily therapist-directed activity and weekly phone calls, use a mHealth-CR app to track activity, heart rate and access educational materials, and use a wearable wrist activity monitoring device (such as Fitbit or Apple Watch).
Treatment:
Behavioral: mHealth-CR
Behavioral: Wearable activity monitoring device
Behavioral: Communication with exercise therapist
Usual Care
Active Comparator group
Description:
Participants in usual care arm will receive standard medical care as determined by their physician. They will also use a wearable wrist activity monitoring device.
Treatment:
Behavioral: Wearable activity monitoring device

Trial contacts and locations

1

Loading...

Central trial contact

John Dodson, MD; Harmony Reynolds, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems